Controlled comparison of gastric lesions and gastrointestinal blood loss with fluproquazone and acetylsalicylic acid (ASA) in healthy subjects.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001241:Aspirin / Q000009:adverse effects*; D001779:Blood Coagulation Factors / Q000032:analysis; D001792:Blood Platelets / Q000378:metabolism; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced*; D005773:Gastroscopy; D006801:Humans; D008297:Male; D011799:Quinazolines / Q000009:adverse effects*; D052999:Quinazolinones; D013276:Stomach Ulcer / Q000139:chemically induced*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D001779:Blood Coagulation Factors; D011799:Quinazolines; D052999:Quinazolinones; D001241:Aspirin; C023491:fluproquazone